+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
United States OLINVYK Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States OLINVYK Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
United States DSUVIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States DSUVIA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
United States MAXIGESIC IV Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States MAXIGESIC IV Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
US VOQUEZNA TRIPLE and DUAL PAKs Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

US VOQUEZNA TRIPLE and DUAL PAKs Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • United States
From
KALYDECO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KALYDECO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
LYBALVI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LYBALVI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
LATUDA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LATUDA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
REXULTI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REXULTI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
REAGILA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REAGILA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
CAPLYTA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CAPLYTA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
ABILIFY MYCITE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ABILIFY MYCITE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032 - Product Thumbnail Image

IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 100 Pages
  • Global
From
XOLAIR Marketed Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XOLAIR Marketed Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
XENICAL (Orlistat), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XENICAL (Orlistat), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
From
SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
GIVINOSTAT Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

GIVINOSTAT Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more